Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06880302 · ClinicalTrials.gov registry record
Male Infertility and Assisted Reproductive Technologies Research Biobank
A clinical trial of Infertility (IVF Patients) and Male Infertility, sponsored by Reproductive Medicine Associates of New Jersey.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06880302 is a study of Infertility (IVF Patients) and Male Infertility that is actively recruiting participants, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 1,000 participants, above the 368-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (172% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06880302, a study of Infertility (IVF Patients) and Male Infertility, is actively recruiting participants, sponsored by Reproductive Medicine Associates of New Jersey.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART).
Conditions Studied
Study Locations (1)
New Jersey
- RMANJ - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-03-04 |
| Est. Completion | 2032-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06880302
The ClinicalTrials.gov registry entry for NCT06880302 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 368-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (172% higher). The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Infertility (IVF Patients) appearing as the primary indexed condition, and to 0 interventions.
NCT06880302 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06880302 about?
NCT06880302 is a clinical study titled "Male Infertility and Assisted Reproductive Technologies Research Biobank". The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART).
What is the current status of trial NCT06880302?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-03-04. Estimated completion is 2032-12.
What conditions does trial NCT06880302 study?
This clinical trial studies the following conditions: Infertility (IVF Patients), Male Infertility.
Who is sponsoring clinical trial NCT06880302?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06880302 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility (IVF Patients)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Quantifying Uterine Elastography in Menstruating Women
RECRUITING
-
The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
RECRUITING · NA
-
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
RECRUITING · Phase 3
-
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
RECRUITING · Phase 3
-
Ketorolac Use and Fresh Embryo Transfer Outcomes
RECRUITING · Phase 4
-
Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.